Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX was delisted on the 23rd of January, 2024.
50 hedge funds and large institutions have $30.2M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 17 closing their positions.
18% less funds holding
Funds holding: 61 → 50 (-11)
22% less capital invested
Capital invested by funds: $38.9M → $30.2M (-$8.66M)
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$1.87M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.13M |
| 3 |
Renaissance Technologies
New York
|
+$661K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$617K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$148K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.75M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$1.14M |
| 3 |
SG Americas Securities
New York
|
-$750K |
| 4 |
EP
Eversept Partners
New York
|
-$299K |
| 5 |
HCA
Harbor Capital Advisors
Chicago,
Illinois
|
-$168K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HWAM
51
Hennion & Walsh Asset Management
Parsippany,
New Jersey
| – | -$117K | -16,418 | Closed |
|
|
IC
52
Ikarian Capital
Dallas,
Texas
| – | -$110K | -15,561 | Closed |
|
53
Legal & General Group
London,
United Kingdom
| – | -$58K | -8,142 | Closed |
|
54
Goldman Sachs
New York
| – | -$26K | -3,679 | Closed |
|
|
HF
55
HRT Financial
New York
| – | -$18K | -2,599 | Closed |
|
|
RE
56
RBC Europe
London,
United Kingdom
| – | -$14K | -1,950 | Closed |
|
|
VPIM
57
Vanguard Personalized Indexing Management
Oakland,
California
| – | -$12K | -1,626 | Closed |
|
58
Two Sigma Advisers
New York
| – | -$11K | -1,590 | Closed |
|
|
BFM
59
Boothbay Fund Management
New York
| – | -$11K | -1,493 | Closed |
|
60
US Bancorp
Minneapolis,
Minnesota
| – | -$7K | -924 | Closed |
|
|
ACM
61
Aquatic Capital Management
Chicago,
Illinois
| – | -$3K | -380 | Closed |
|
|
QT
62
Quantbot Technologies
New York
| – | -$2K | -330 | Closed |
|
|
SPIA
63
Steward Partners Investment Advisory
New York
| – | -$1K | -100 | Closed |
|
64
Simplex Trading
Chicago,
Illinois
| – | +$491 | +87 | New |
|
ORTX Hedge Fund Activity: Q2 2022 in Review
50 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q2 2022, worth a combined $30.2M — down 22% from $38.9M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ORTX and 8 opened new positions — a net loss of 9 holders — while 13 trimmed existing stakes and 7 added.
The largest buyer was Temasek Holdings, adding an estimated $1.87M. The largest seller was RA Capital Management, cutting an estimated $3.75M.
- 50 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q2 2022, down from 61 in Q1 2022.
- Funds reported $30.2M of Orchard Therapeutics plc American Depositary Shares stock for Q2 2022, down 22% quarter-over-quarter.
- 8 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q2 2022 and 17 closed out, a net change of -9 holders.
- The largest Orchard Therapeutics plc American Depositary Shares buyer in Q2 2022 was Temasek Holdings, an estimated $1.87M added.
- The largest Orchard Therapeutics plc American Depositary Shares seller in Q2 2022 was RA Capital Management, an estimated $3.75M sold.
Based on aggregated 13F filings for Q2 2022.